9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.13% | -20.27% | -46.15% | -20.91% | -20.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.15% | 29.56% | 37.01% | 2.54% | -38.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -95.98% | -- | -- | -- | -- |
| Total Current Assets | -72.14% | 78.92% | -41.13% | -19.80% | -21.80% |
|
|
|||||
| Total Current Assets | -72.14% | 78.92% | -41.13% | -19.80% | -21.80% |
| Net Property, Plant & Equipment | -12.96% | -12.04% | -9.88% | -9.47% | -6.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.29% | -99.97% | 420,296.43% | 0.00% | 0.00% |
| Total Assets | -71.90% | -21.33% | 33.73% | -19.75% | -21.74% |
|
|
|||||
| Total Accounts Payable | -16.27% | 251.47% | -38.19% | 21.67% | -21.47% |
| Total Accrued Expenses | 31.46% | -35.35% | -2.61% | 11.18% | 4.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -99.68% | 627.23% | 4,549.31% | 3.01% | 3.10% |
| Total Finance Division Other Current Liabilities | -71.36% | -18.51% | -- | -- | -- |
| Total Other Current Liabilities | -71.36% | -18.51% | -- | -- | -- |
| Total Current Liabilities | -49.25% | 138.64% | 37.72% | 13.56% | -2.75% |
|
|
|||||
| Total Current Liabilities | -49.25% | 138.64% | 37.72% | 13.56% | -2.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.30% | -23.85% | -18.87% | -15.45% | -13.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -49.22% | 7.23% | 204.30% | 13.22% | -2.89% |
|
|
|||||
| Common Stock & APIC | 2.40% | 0.41% | 0.34% | 1.08% | 0.33% |
| Retained Earnings | -6.52% | -5.94% | -4.89% | -6.18% | -6.72% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -362.41% | -82.17% | -39.05% | -28.62% | -25.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -362.41% | -82.17% | -39.05% | -28.62% | -25.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -362.41% | -82.17% | -39.05% | -28.62% | -25.63% |
|
|
|||||
